Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | LLB Swiss Investment AGSocietà | -3,85M | 100,79k | Vendita | 0,03 | 41,15M | -8,55% |
| 2026-04-15 | Condire Investors, LLCSocietà | 191,00M | 5,56M | Acquisto | 0,03 | 289,38M | 194,15% |
| 2026-04-15 | Canaccord Genuity Asset Management LimitedSocietà | 65,63M | 0,00 | Acquisto | - | 112,63M | 139,63% |
| 2026-04-21 | Mr. Sam PazukiMD, CEO & Executive Director | -4,32M | 0,00 | Other Derivative Disposition | - | 4,31M | -50,09% |
| 2026-04-15 | Mr. Sam PazukiMD, CEO & Executive Director | 851,06k | 29,12k | Acquisto | 0,03 | 8,57M | 11,03% |
| 2026-04-21 | Mr. Sam PazukiMD, CEO & Executive Director | -1,47M | 0,00 | Other Derivative Disposition | - | 25,30M | -5,51% |
| 2026-04-16 | Cupel Advisory CorpSocietà | 1.000,00k | 29,17k | Acquisto | 0,03 | 2,18M | 84,75% |
| 2026-04-16 | Mr. James Carr WithallIndependent Non-Executive Director | 350,00k | 10,21k | Acquisto | 0,03 | 1,35M | 35,00% |
| 2026-04-14 | Condire Investors, LLCSocietà | 191,00M | 5,55M | Acquisto | 0,03 | 289,38M | 194,15% |
| 2026-04-15 | Franklin Resources, Inc.Società | 75,00M | 2,15M | Acquisto | 0,03 | 118,53M | 172,31% |
| 2026-04-14 | Nokomis Capital, L.L.C.Società | 135,00M | 3,85M | Acquisto | 0,03 | 135,00M | - |
| 2026-03-05 | Condire Investors, LLCSocietà | 98,38M | 3,90M | Acquisto | 0,04 | 98,38M | - |
| 2024-12-10 | B2Gold Corp.Società | 27,00M | 860,14k | Acquisto | 0,03 | 31,01M | 673,27% |
| 2025-12-10 | Mr. Justin OsborneIndependent Non-Executive Chairman | 1.000,00k | 24,57k | Acquisto | 0,02 | 2,94M | 51,52% |
| 2025-12-10 | Cupel Advisory CorpSocietà | 300,00k | 9,02k | Acquisto | 0,03 | 1,18M | 34,09% |
| 2025-12-10 | Mr. Justin OsborneIndependent Non-Executive Chairman | 1.000,00k | 24,57k | Acquisto | 0,02 | 2,79M | 55,84% |
| 2025-12-05 | Cupel Advisory CorpSocietà | 200,00k | 6,49k | Acquisto | 0,03 | 880,00k | 29,41% |
| 2025-12-04 | Mr. Sam PazukiMD, CEO & Executive Director | 350,00k | 8,28k | Acquisto | 0,02 | 7,72M | 4,75% |
| 2025-12-03 | Mr. James Carr WithallIndependent Non-Executive Director | 500,00k | 14,34k | Acquisto | 0,03 | 1.000,00k | 100,00% |
| 2025-12-03 | Mr. Sam PazukiMD, CEO & Executive Director | 957,58k | 25,63k | Acquisto | 0,02 - 0,03 | 7,37M | 14,94% |
| 2025-10-23 | Mr. Sam PazukiMD, CEO & Executive Director | 1,08M | 76,91 | Derivative Exercise and Retained Stock | 0,00 | 6,41M | 20,34% |
| 2025-07-15 | LLB Swiss Investment AGSocietà | 10,31M | 229,00k | Acquisto | 0,02 | 45,00M | 29,73% |
| 2025-05-23 | LLB Swiss Investment AGSocietà | -822,06k | 18,72k | Vendita | 0,02 | 45,00M | -1,79% |
| 2025-05-26 | LLB Swiss Investment AGSocietà | -898,94k | 20,04k | Other Disposition | 0,02 | 45,00M | -1,96% |
| 2025-07-18 | Ms. Carol MarinkovichExecutive Director & Company Secretary | 540,88k | 0,00 | Derivative Exercise and Retained Stock | - | 865,39k | 166,68% |
| 2025-07-04 | Ms. Carol MarinkovichExecutive Director & Company Secretary | 540,88k | 10,98k | Derivative Exercise and Retained Stock | 0,02 | 324,50k | -249,97% |
| 2025-07-18 | Mr. Sam PazukiMD, CEO & Executive Director | 1,08M | 41,71k | Derivative Exercise and Retained Stock | 0,02 - 0,04 | 6,41M | 20,34% |
| 2025-07-04 | Cupel Advisory CorpSocietà | 1,25M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,25M | - |
| 2025-07-04 | Mr. Ryan FinkelsteinCFO | 559,94k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,04 | 559,94k | - |
| 2025-07-04 | Mr. Ryan FinkelsteinCFO | 1,34M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,34M | - |
| 2025-07-07 | Mr. Michael Bethel SkeadPresident | 6,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,04 | 8,56M | 234,67% |
| 2025-07-04 | Mr. Sam PazukiMD, CEO & Executive Director | 3,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,04 | 26,78M | 12,62% |
| 2025-07-04 | Mr. Sam PazukiMD, CEO & Executive Director | 5,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 12,10M | 70,38% |
| 2025-07-04 | Ms. Carol MarinkovichExecutive Director & Company Secretary | 1,88M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-04 | Ms. Carol MarinkovichExecutive Director & Company Secretary | -1,03M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-07-04 | Mr. Sam PazukiMD, CEO & Executive Director | -4,37M | 0,00 | Other Derivative Disposition | - | - | - |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
